Froedtert & MCW health network patients who used DTx achieved a 91 percent medication adherence or better, with lower average glucose levels and LDL cholesterol levels.
Patients with Chronic Conditions, Including Diabetes and Hypertension Were Prescribed Ingestible Sensor
The ability to include DTx in a medical record not only improves care coordination but it individualizes and broadens the view of the person. Froedtert wanted to include wearable and ingestible sensors to better understand how certain patients were doing between appointments and increasingly help personalize and optimize their regimen. Working with Xealth, the health system wanted to simplify a multi-step manual process for providers.
Through Xealth, Froedtert patients who qualified for DTx are automatically recognized and presented to the clinician as part of the normal EHR prescribing workflow. When the patient accepts the DTx order, the hip sensor is mailed, their prescription is activated and sent to the pharmacy. Xealth links this information back to the EHR so that the care team knows they accepted the order, and their hip sensor and medication are on their way.
Once patients are using the DTx program, the data generated from the sensors is automatically linked back to the patient record through Xealth, enabling patients to share data about their experiences with the medication back to their care team. Froedtert & MCW health network patients who used DTx achieved a 91 percent medication adherence or better, with lower average glucose levels and LDL cholesterol levels.